{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:00:21Z","timestamp":1769860821273,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chinese State Key Project for Basic Research","award":["2014CBA02001"],"award-info":[{"award-number":["2014CBA02001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1245\/s10434-019-07586-3","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T20:08:43Z","timestamp":1562011723000},"page":"3682-3692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Fibrinogen\u2013Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases"],"prefix":"10.1245","volume":"26","author":[{"given":"Yan-Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Cai","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"issue":"6","key":"7586_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"7586_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"7586_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000449348","volume":"6","author":"RP Jones","year":"2016","unstructured":"Jones RP, Kokudo N, Folprecht G, et al. Colorectal liver metastases: a critical review of state of the art. Liver Cancer. 2016;6(1):66\u201371.","journal-title":"Liver Cancer."},{"key":"7586_CR4","doi-asserted-by":"crossref","unstructured":"Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl 3:iii1\u20139.","DOI":"10.1093\/annonc\/mdu260"},{"issue":"7","key":"7586_CR5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/bjs.7032","volume":"97","author":"EJ Morris","year":"2010","unstructured":"Morris EJ, Forman D, Thomas JD, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg. 2010;97(7):1110\u20138.","journal-title":"Br J Surg."},{"issue":"10","key":"7586_CR6","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/bjs.10191","volume":"103","author":"J Hallet","year":"2016","unstructured":"Hallet J, Sa Cunha A, Adam R, et al. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases. Br J Surg. 2016;103(10):1366\u201376.","journal-title":"Br J Surg."},{"issue":"11","key":"7586_CR7","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493\u2013503.","journal-title":"Lancet Oncol."},{"issue":"6","key":"7586_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell."},{"issue":"7203","key":"7586_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344.","journal-title":"Nature."},{"issue":"1","key":"7586_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41416-018-0095-9","volume":"119","author":"RD Dolan","year":"2018","unstructured":"Dolan RD, McSorley ST, Park JH, et al. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Br J Cancer. 2018;119(1):40\u201351.","journal-title":"Br J Cancer."},{"issue":"23","key":"7586_CR11","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, et al. Systemic immune\u2013inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212\u201322.","journal-title":"Clin Cancer Res."},{"issue":"4","key":"7586_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/bjs.10425","volume":"104","author":"VP Jagadesham","year":"2017","unstructured":"Jagadesham VP, Lagarde SM, Immanuel A, Griffin SM. Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. Br J Surg. 2017;104(4):401\u20137.","journal-title":"Br J Surg."},{"issue":"2","key":"7586_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/JTO.0000000000000399","volume":"10","author":"NA Cannon","year":"2015","unstructured":"Cannon NA, Meyer J, Iyengar P, et al. Neutrophil-lymphocyte and platelet\u2013lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol. 2015;10(2):280\u20135.","journal-title":"J Thorac Oncol."},{"issue":"3","key":"7586_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JC Chan","year":"2017","unstructured":"Chan JC, Chan DL, Diakos CI, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539\u201346.","journal-title":"Ann Surg."},{"issue":"9","key":"7586_CR15","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1245\/s10434-014-4354-6","volume":"22","author":"RL Araujo","year":"2015","unstructured":"Araujo RL, Gonen M, Herman P. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis. Ann Surg Oncol. 2015;22(9):3070\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"7586_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdx738","volume":"29","author":"T Yoshino","year":"2018","unstructured":"Yoshino T, Arnold D, Taniguchi H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol. 2018;29(1):44\u201370.","journal-title":"SSO and TOS. Ann Oncol."},{"issue":"9617","key":"7586_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","volume":"371","author":"B Nordlinger","year":"2008","unstructured":"Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371(9617):1007\u201316.","journal-title":"Lancet."},{"issue":"3","key":"7586_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1245\/s10434-008-0267-6","volume":"16","author":"Y Kishi","year":"2009","unstructured":"Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol. 2009;16(3):614\u201322.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"7586_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archsurg.2011.50","volume":"146","author":"CP Neal","year":"2011","unstructured":"Neal CP, Mann CD, Garcea G, Briggs CD, Dennison AR, Berry DP. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg. 2011;146(4):471\u20138.","journal-title":"Arch Surg."},{"key":"7586_CR20","doi-asserted-by":"crossref","unstructured":"Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47(17):2633\u201341.","DOI":"10.1016\/j.ejca.2011.03.028"},{"issue":"4","key":"7586_CR21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/bjc.2013.815","volume":"110","author":"B Ghanim","year":"2014","unstructured":"Ghanim B, Hoda MA, Klikovits T, et al. Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma. Br J Cancer. 2014;110(4):984\u201390.","journal-title":"Br J Cancer."},{"issue":"6","key":"7586_CR22","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/sj.bjc.6605547","volume":"102","author":"V Seebacher","year":"2010","unstructured":"Seebacher V, Polterauer S, Grimm C, et al. The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial. Br J Cancer. 2010;102(6):952\u20136.","journal-title":"Br J Cancer."},{"issue":"10","key":"7586_CR23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1634\/theoncologist.2009-0079","volume":"14","author":"S Polterauer","year":"2009","unstructured":"Polterauer S, Grimm C, Seebacher V, et al. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist. 2009;14(10):979\u201385.","journal-title":"Oncologist."},{"issue":"2","key":"7586_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/annonc\/mds336","volume":"24","author":"C Aggarwal","year":"2013","unstructured":"Aggarwal C, Meropol NJ, Punt CJ, et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol. 2013;24(2):420\u20138.","journal-title":"Ann Oncol."},{"issue":"3","key":"7586_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309\u201318; discussion 18\u201321.","journal-title":"Ann Surg."},{"issue":"5","key":"7586_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/bjs.10447","volume":"104","author":"K Imai","year":"2017","unstructured":"Imai K, Allard MA, Castro Benitez C, et al. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. Br J Surg. 2017;104(5):570\u20139.","journal-title":"Br J Surg."},{"issue":"10","key":"7586_CR27","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/annonc\/mds053","volume":"23","author":"T Ruers","year":"2012","unstructured":"Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23(10):2619\u201326.","journal-title":"Ann Oncol."},{"issue":"6","key":"7586_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ejso.2018.02.210","volume":"44","author":"K Wang","year":"2018","unstructured":"Wang K, Xu D, Yan XL, Poston G, Xing BC. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis. Eur J Surg Oncol. 2018;44(6):771\u20137.","journal-title":"Eur J Surg Oncol."},{"issue":"30","key":"7586_CR29","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381\u201397.","journal-title":"Stat Med."},{"issue":"21","key":"7586_CR30","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res."},{"issue":"2","key":"7586_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/bjc.2015.87","volume":"113","author":"JK Pine","year":"2015","unstructured":"Pine JK, Morris E, Hutchins GG, et al. Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer. 2015;113(2):204\u201311.","journal-title":"Br J Cancer."},{"issue":"6","key":"7586_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bjs.10095","volume":"103","author":"YY Wang","year":"2016","unstructured":"Wang YY, Zhong JH, Su ZY, et al. Albumin\u2013bilirubin versus Child\u2013Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg. 2016;103(6):725\u201334.","journal-title":"Br J Surg."},{"issue":"34","key":"7586_CR33","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","volume":"23","author":"JH Chen","year":"2017","unstructured":"Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune\u2013inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261\u201372.","journal-title":"World J Gastroenterol."},{"issue":"1","key":"7586_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1245\/s10434-014-3857-5","volume":"22","author":"S Matsuda","year":"2015","unstructured":"Matsuda S, Takeuchi H, Kawakubo H, et al. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score. Ann Surg Oncol. 2015;22(1):302\u201310.","journal-title":"Ann Surg Oncol."},{"key":"7586_CR35","first-page":"4925498","volume":"2018","author":"Q Xu","year":"2018","unstructured":"Xu Q, Yan Y, Gu S, et al. A novel inflammation-based prognostic score: the fibrinogen\/albumin ratio predicts prognoses of patients after curative resection for hepatocellular carcinoma. J Immunol Res. 2018;2018:4925498.","journal-title":"J Immunol Res."},{"issue":"4","key":"7586_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jso.23845","volume":"111","author":"A Giakoustidis","year":"2015","unstructured":"Giakoustidis A, Neofytou K, Khan AZ, Mudan S. Neutrophil to lymphocyte ratio predicts pattern of recurrence in patients undergoing liver resection for colorectal liver metastasis and thus the overall survival. J Surg Oncol. 2015;111(4):445\u201350.","journal-title":"J Surg Oncol."},{"issue":"10","key":"7586_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12032-014-0239-6","volume":"31","author":"K Neofytou","year":"2014","unstructured":"Neofytou K, Smyth EC, Giakoustidis A, Khan AZ, Cunningham D, Mudan S. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor. Med Oncol. 2014;31(10):239.","journal-title":"Med Oncol."},{"issue":"9","key":"7586_CR38","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/bjs.10838","volume":"105","author":"GA Margonis","year":"2018","unstructured":"Margonis GA, Sasaki K, Gholami S, et al. Genetic and morphological evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105(9):1210\u201320.","journal-title":"Br J Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07586-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T23:18:10Z","timestamp":1593472690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07586-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["7586"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07586-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yan-Yan Wang, Zhen-Zhen Liu, Da Xu, Ming Liu, Kun Wang, and Bao-Cai Xing declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}